4.8 Article

The Transcription Factor GATA3 Controls Cell Fate and Maintenance of Type 2 Innate Lymphoid Cells

Journal

IMMUNITY
Volume 37, Issue 4, Pages 634-648

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2012.06.020

Keywords

-

Categories

Funding

  1. Deutsche Forschungsgemeinschaft (SGBM) [SFB620/A14, GRK1104]
  2. Bundesministerium fur Bildung und Forschung Centrum fur Chronische Immundefizienz
  3. EU [PAS_241506]
  4. Boehringer Ingelheim
  5. Medical Research Council [G0800784, G0900424, G0800784B] Funding Source: researchfish
  6. MRC [G0800784, G0900424] Funding Source: UKRI

Ask authors/readers for more resources

Innate lymphoid cells (ILCs) reside at mucosal surfaces and control immunity to intestinal infections. Type 2 innate lymphoid cells (ILC2s) produce cytokines such as IL-5 and IL-13, are required for immune defense against helminth infections, and are involved in the pathogenesis of airway hyperre-activity. Here, we have investigated the role of the transcription factor GATA-3 for ILC2 differentiation and maintenance. We showed that ILC2s and their lineage-specified bone marrow precursors (ILC2Ps), as identified here, were characterized by continuous high expression of GATA-3. Analysis of mice with temporary deletion of GATA-3 in all ILCs showed that GATA-3 was required for the differentiation and maintenance of ILC2s but not for ROR gamma t(+) ILCs. Thus, our data demonstrate that GATA-3 is essential for ILC2 fate decisions and reveal similarities between the transcriptional programs controlling ILC and T helper cell fates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available